Related references
Note: Only part of the references are listed.Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature
Chakrabhavi Dhananjaya Mohan et al.
SEMINARS IN CANCER BIOLOGY (2022)
Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression
Ryota Takahashi et al.
GUT (2021)
Interleukin 35 Regulatory B Cells
Jin Kyeong Choi et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma
X. Liu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer
Tenglong Zhang et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Regulatory B cells and T cell Regulation in Cancer
Motoki Horii et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Immunometabolic Interplay in the Tumor Microenvironment
Irem Kaymak et al.
CANCER CELL (2021)
Cancer-associated adipocytes as immunomodulators in cancer
Qi Wu et al.
BIOMARKER RESEARCH (2021)
Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling
Dimitra Manou et al.
SEMINARS IN CANCER BIOLOGY (2020)
IL-35, a double-edged sword in cancer
Zahra Yazdani et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease
Haijian Xing et al.
BMC IMMUNOLOGY (2020)
Chemotherapy Induces Cancer-Fighting B Cells
Zhida Liu et al.
CELL (2020)
Elevated levels of IL-17A and IL-35 in plasma and bronchoalveolar lavage fluid are associated with checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer
Yi Na Wang et al.
ONCOLOGY LETTERS (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages
Ji Young Kang et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Overcoming Wnt-β-catenin dependent anticancer therapy resistance in leukaemia stem cells
John M. Perry et al.
NATURE CELL BIOLOGY (2020)
Mechanisms of beta-catenin-induced adrenal hyperplasia
Shimona Starling
NATURE REVIEWS ENDOCRINOLOGY (2020)
PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia
Yuqing Dong et al.
FRONTIERS IN IMMUNOLOGY (2020)
Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression
Helal F. Hetta et al.
VACCINES (2020)
The lnc-CITED2-2:1 inhibits metastasis via inhibiting CITED2 and epithelial-mesenchymal transition in gallbladder cancer
Sheng Shen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
JAK/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B
Yuejiao Dong et al.
LIFE SCIENCES (2020)
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li et al.
MOLECULAR CANCER (2020)
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Jialin Zhu et al.
CANCER CELL INTERNATIONAL (2020)
IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1
Xiao Li et al.
FEBS OPEN BIO (2020)
Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer
Jin Shang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeting novel inhibitory receptors in cancer immunotherapy
Quan-Quan Ding et al.
SEMINARS IN IMMUNOLOGY (2020)
The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
Xiaoyang Zhai et al.
CANCER BIOLOGY & MEDICINE (2020)
Interleukin 39: a new member of interleukin 12 family
Zhiyu Lu et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Low frequency of IL-10+ B cells in patients with atherosclerosis is related with inflammatory condition
Hector Rincon-Arevalo et al.
HELIYON (2020)
Different expression levels of interleukin-35 in asthma phenotypes
Wei Li et al.
RESPIRATORY RESEARCH (2020)
Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer
Nazanin Chatrabnous et al.
CYTOKINE (2019)
A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity
Min Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype
James Godfrey et al.
BLOOD (2019)
IL-35Ig-expressing dendritic cells induce tolerance via Arginase 1
Eleonora Panfili et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity
Yifan Li et al.
ONCOLOGY REPORTS (2019)
Notch signaling pathway regulates CD4+CD25+CD127dim/- regulatory T cells and T helper 17 cells function in gastric cancer patients
Lu Yang et al.
BIOSCIENCE REPORTS (2019)
Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer
Lisanne Heim et al.
BRITISH JOURNAL OF CANCER (2019)
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
Deepali Sawant et al.
NATURE IMMUNOLOGY (2019)
Treg cell IL-10 and IL-35 exhaust CD8+ T cells in tumors
Martina Damo et al.
NATURE IMMUNOLOGY (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells
Claudia Tanja Mierke
REPORTS ON PROGRESS IN PHYSICS (2019)
Teamwork by IL-10+and IL-35+ Tregs
Christine M. McIntosh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Interleukin-35 Dampens CD8+ T Cells Activity in Patients With Non-viral Hepatitis-Related Hepatocellular Carcinoma
Lanlan Yang et al.
FRONTIERS IN IMMUNOLOGY (2019)
The regulatory B cell-mediated peripheral tolerance maintained by mast cell IL-5 suppresses oxazolone-induced contact hypersensitivity
Hyuk Soon Kim et al.
SCIENCE ADVANCES (2019)
Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
Frederique Larousserie et al.
FRONTIERS IN ONCOLOGY (2019)
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
Bilikis Aderonke Abolarinwa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Immunoregulatory Functions of the IL-12 Family of Cytokines in Antiviral Systems
Yifei Guo et al.
VIRUSES-BASEL (2019)
WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment
Xin Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-35 inhibits CD8+ T cells activity by suppressing expression of costimulatory molecule CD28 and Th1 cytokine production
Hua Jiang et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer
Penglei Ge et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells
Min Lian et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma
Su Jong Yu et al.
JOURNAL OF HEPATOLOGY (2019)
BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis
Shipra Das et al.
ONCOGENE (2019)
PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions
Liliang Xia et al.
ONCOLOGIST (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer
Hong-Min Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice
Chongbiao Huang et al.
GASTROENTEROLOGY (2018)
IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases
Manouchehr Teymouri et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages
Amber E. de Groot et al.
Oncotarget (2018)
Mechanisms of Tolerance induction by Dendritic Cells In Vivo
Hitoshi Hasegawa et al.
FRONTIERS IN IMMUNOLOGY (2018)
A novel MDSC-induced PD-1(-)PD-L1(+) B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties
Meng Shen et al.
ONCOIMMUNOLOGY (2018)
Administration of Interleukin-35-Conditioned Autologous Tolerogenic Dendritic Cells Prolong Allograft Survival After Heart Transplantation
Xianglan Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization
Chih-Chan Lee et al.
NATURE COMMUNICATIONS (2018)
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells
Shengnan Hao et al.
CARCINOGENESIS (2018)
Immune Checkpoint Inhibitor Toxicity in 2018
Douglas B. Johnson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Activated β-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity
Tomokazu Sumida et al.
NATURE IMMUNOLOGY (2018)
Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification Inhibitors
Wanyu Sun et al.
GENES (2018)
Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
Anne Huber et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
Qingshui Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
Chenchao Zhou et al.
ONCOTARGETS AND THERAPY (2017)
Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression
Chongbiao Huang et al.
NATURE COMMUNICATIONS (2017)
Driving better and safer HER2-specific CARs for cancer therapy
Xianqiang Liu et al.
ONCOTARGET (2017)
Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
QiangYue Jiang et al.
Oncotarget (2017)
IL-35 induces N2 phenotype of neutrophils to promote tumor growth
Jiu-Ming Zou et al.
ONCOTARGET (2017)
Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist
Keun Ah Ryu et al.
SCIENTIFIC REPORTS (2017)
Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line
Lili Yang et al.
JOURNAL OF CANCER (2017)
Interleukin-35-Producing CD8α+ Dendritic Cells Acquire a Tolerogenic State and Regulate T Cell Function
Sergio Haller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
Eva M. Palsson-McDermott et al.
FRONTIERS IN IMMUNOLOGY (2017)
Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
Yi-Peng Fu et al.
BRITISH JOURNAL OF CANCER (2016)
A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice
Xiaoqian Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Elevated level of Interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3
Yanhui Ma et al.
ONCOTARGET (2016)
Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members
Karen O. Dixon et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Regulatory B Cells: Origin, Phenotype, and Function
Elizabeth C. Rosser et al.
IMMUNITY (2015)
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shabnam Shalapour et al.
NATURE (2015)
Microenvironment and tumor cell plasticity: An easy way out
Maria Letizia Taddei et al.
CANCER LETTERS (2013)
Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis
Zhihui Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
The composition and signaling of the IL-35 receptor are unconventional
Lauren W. Collison et al.
NATURE IMMUNOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC
Maria Seyer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
IL-35-mediated induction of a potent regulatory T cell population
Lauren W. Collison et al.
NATURE IMMUNOLOGY (2010)
A Novel p40-Independent Function of IL-12p35 Is Required for Progression and Maintenance of Herpes Stromal Keratitis
Gregory M. Frank et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Share Paper
